Cross Country Healthcare, Inc. is a U.S.-based provider specializing in talent management and consultative advisory services for healthcare organizations. The company operates ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $0.04 · Revenue $248.97M · 5 analysts
Est. EPS $0.09 · Revenue $984.14M · 4 analysts
Est. EPS $0.00 · Revenue $249.01M · 1 analysts
Est. EPS $0.03 · Revenue $248.00M · 3 analysts
EPS $-0.02 · Revenue $293.41M
EPS $-0.44 · Revenue $1.34B
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $1.1B | -21.6% | +1.8% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $-94.9M | -551.6% | +94.9% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +18.7% | -8.5% | -10.1% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | -0.3% | +73.8% | +73.0% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | -9.0% | -730.7% | +94.9% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $40.1M | -64.0% | -79.5% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | +3.8% | -54.1% | -79.8% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 0.7% | -22.3% | -9.0% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 3.78x | +35.7% | -12.8% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $449.0M | -23.8% | +0.5% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | -2.93 vs 0.10 | -3036.7% | -0.14 vs 0.04 | -422.2% |
| Revenue Surprise | $1.1B vs $1.1B | -1.6% | $241.1M vs $249.0M | -3.2% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Jul 21, 2026 | Veizaga Marvin | officer: Chief Accounting Officer | Common Stock | A | 16,797 | — |
| Jul 21, 2026 | Veizaga Marvin | officer: Chief Accounting Officer | Common Stock | D | 16,797 | $13.25 |
| Jul 21, 2026 | Hawkins Amiee Lin | officer: Chief Operating Officer | Common Stock | A | 27,897 | — |
| Jul 21, 2026 | Hawkins Amiee Lin | officer: Chief Operating Officer | Common Stock | D | 27,897 | $13.25 |
| Jul 21, 2026 | Krug Marc S. | officer: Group President, Delivery | Common Stock | A | 47,120 | — |
Operator: Good afternoon, everyone, and welcome to the Cross Country Healthcare's Earnings Conference Call for the Fourth Quarter 2025. Please be advised that this call is being recorded, and a replay of the webcast will be available on the company's website. Details for accessing the audio replay can be found in the company's earnings release issued this afternoon. At the conclusion of the prepared remarks, I will open the lines for questions. I would now like to turn the call over to Josh Vogel, Cross Country Healthcare's Vice President of Investor Relations. Thank you, sir. You may go ahead. Joshua Vogel: Thank you, and good afternoon, everyone. I'm joined today by our Chairman of the Board and Chief Executive Officer, Kevin Clark; as well as Bill Burns, our Chief Financial Officer; Marc Krug, Group President of Delivery; and Amiee Hawkins, Chief Solutions and Operations Officer. Today's call will include a discussion of our financial results for the fourth quarter of 2025 as well as our outlook for the first quarter of 2026. A copy of our earnings press release is available on our website at crosscountry.com. Please note that certain statements made on this call may constitute forward-looking statements. These statements reflect the company's beliefs based upon information currently available to it. As noted in our press release, forward-looking statements can vary materially from actual results and are subject to known and unknown risks, uncertainties and other factors, including those contained in the company's 2024 annual report on Form 10-K and quarterly reports on Form 10-Q as well as in other filings with the SEC. The company does not intend to update guidance or any of its forward-looking statements prior to the next earnings release. Additionally, we reference non-GAAP financial measures such as adjusted EBITDA or adjusted earnings per share. Such non-GAAP financial measures are provided as additional information and should not be considered substitutes for or superior to those calculated in accordance with U.S. GAAP. More information related to these non-GAAP financial measures is contained in our press release. With that, I will now turn the call over to our Chief Executive Officer, Kevin Clark. Kevin Clark: Good afternoon, and thank you for joining us. As you know, 2025 was a challenging year for Cross Country Healthcare. The pending merger introduced uncertainty for our employees and our customers, which weighed on our growth during the year. With that process now behind us, we have improved momentum and a renewed focus across the organization. However, what did not change was the strength of our client relationships, the quality of our clinicians or the financial strength of our balance sheet. I stepped back into the CEO role with a clear objective: restore momentum, sharpen execution and position the company to grow faster than the market again. As reflected in the recent Becker's article on Cross Country, we are advancing a …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
William J. Burns | Executive Vice President & Chief Financial Officer | USD 643,500 | Male | 1970 | Active |
Susan E. Ball | Chief Administrative Officer, Executive Vice President, General Counsel & Secretary | USD 575,000 | Female | 1964 | Active |
Marc Krug | Group President of Delivery, CCN, CCA & CCE | USD 540,000 | Male | 1968 | Active |
Kevin Cronin Clark | Co-Founder, Chairman, President & CEO | USD 537,986 | Male | 1961 | Active |
Chris Tyrell | Chief Information Officer | USD 473,125 | Male | — | Active |
Colin Patrick McDonald | Chief Human Resources Officer | — | Male | 1969 | Active |
Gerald Purgay | Chief Marketing Officer | — | Male | 1961 | Active |
Amiee Hawkins | Chief Operating Officer | — | Female | 1980 | Active |
Karen Varga-Sinka | Director of Corporate Communications | — | Female | — | Active |
Joshua David Vogel | Vice President of Investor Relations | — | Male | — | Active |
Mark Fortunato | Vice President of Corporate Development | — | Male | — | Active |
Marvin Veizaga | Senior Vice President & Chief Accounting Officer | — | Male | 1981 | Active |
Cross Country Healthcare NASDAQ: CCRN stockholders approved the company's proposed merger agreement at a virtual special meeting held July 16, according to remarks delivered during the meeting by Kevin Clark, the company's co-founder, CEO and chairman of the board.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Cross Country Healthcare, Inc. (NASDAQ: CCRN) to Knox Lane for $13.25 per share in cash.Halper Sadeh encourages Cross Country shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigation concerns whether Cross Country and its board of direct.
NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde and Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report.
NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Cross Country Healthcare, Inc. (NASDAQ: CCRN ) related to its sale to KL Criss Cross Intermediate, LLC. Under the terms of the proposed transaction Cross Country shareholders are expected to receive $13.25 per share in cash. Is it a fair deal?
MONSEY, N.Y., July 15, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP has renewed its investigation into the fairness of the proposed sale of Cross Country Healthcare (Nasdaq: CCRN) (“CCRN”) for $13.25 per share in cash to Knox Lane, a private equity firm.
